This trial is enrolling individuals with acute (less than 72 hours), incomplete cervical and thoracic spinal cord injuries to test the safety, tolerability and overall activity in the body (pharmacokinetics) of an experimental drug (ALMB-0166). The drug is believed to reduce local inflammation and scar formation, thus improving nerve growth and recovery. If included, participants will either receive a single dose of: 1) the active drug; or 2) a placebo (inactive) drug. Outcomes will be followed for up to 2 months.
Type
Details
Participants will either receive a single dose of 1) the active drug or 2) the placebo within 72 hours after injury.
Main benefits
General health
Additional benefits
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more